September 29, 2020 -- Fujifilm Irvine Scientific said it has become the exclusive worldwide distributor of cellnest, a recombinant peptide attachment substrate that's designed to provide optimal adhesion and proliferation of stem cells for cell and gene therapy research.
Cellnest, which was designed and manufactured by Fujifilm Irvine Scientific's parent company Fujifilm, mimics the extracellular matrix and enables the adhesion, expansion, and potential differentiation of stem cells, according to the vendor. It's compatible with any adherent cell type that binds to the Arg-Gly-Asp (RGD) domain, an amino acid sequence within the extracellular matrix protein fibronectin that mediates cell attachment, Fujifilm Irvine Scientific said.
Cellnest is a companion product to its Prime-XV stem cell culture media portfolio and is also well-suited for the attachment and growth of mesenchymal stem cells, according to the company.
Copyright © 2020 scienceboard.net